Background: Very few studies describe factors associated with COVID-19 diagnosis in children. Aim: We here describe characteristics and risk factors for COVID-19 diagnosis in children tested in 20 paediatric centres across Italy. Methods: We included cases aged 0-18 years tested between 23 February and 24 May 2020. Our primary analysis focused on children tested because of symptoms/signs suggestive of COVID-19. Results: Among 2,494 children tested, 2,148 (86.1%) had symptoms suggestive of COVID-19. Clinical presentation of confirmed COVID-19 cases included besides fever (82.4%) and respiratory signs or symptoms (60.4%) also gastrointestinal (18.2%), neurological (18.9%), cutaneous (3.8%) and other unspecific influenza-like presentations (17.8%). In multivariate analysis, factors significantly associated with SARSCoV-2 positivity were: exposure history (adjusted odds ratio (AOR): 39.83; 95% confidence interval (CI): 17.52-90.55; p<0.0001), cardiac disease (AOR: 3.10; 95% CI: 1.19-5.02; p<0.0001), fever (AOR: 3.05%; 95% CI: 1.67-5.58; p=0.0003) and anosmia/ ageusia (AOR: 4.08; 95% CI: 1.69-9.84; p=0.002). Among 190 (7.6%) children positive for SARS-CoV-2, only four (2.1%) required respiratory support and two (1.1%) were admitted to intensive care; all recovered. Conclusion: Recommendations for SARS-CoV-2 testing in children should consider the evidence of broader clinical features. Exposure history, fever and anosmia/ ageusia are strong risk factors in children for positive SARS-CoV-2 testing, while other symptoms did not help discriminate positive from negative individuals. This study confirms that COVID-19 was a mild disease in the general paediatric population in Italy. Further studies are needed to understand risk, clinical spectrum and outcomes of COVID-19 in children with preexisting conditions.

Characteristics and risk factors for SARS-CoV-2 in children tested in the early phase of the pandemic: A cross-sectional study, Italy, 23 February to 24 May 2020 / Lazzerini M., Sforzi I., Trapani S., Biban P., Silvagni D., Villa G., Tibaldi J., Bertacca L., Felici E., Perricone G., Parrino R., Gioe C., Lega S., Conte M., Marchetti F., Magista A., Berlese P., Martelossi S., Vaienti F., Valletta E., et al.. - In: EUROSURVEILLANCE. - ISSN 1025-496X. - ELETTRONICO. - 26:(2021), pp. 1-12. [10.2807/1560-7917.ES.2021.26.14.2001248]

Characteristics and risk factors for SARS-CoV-2 in children tested in the early phase of the pandemic: A cross-sectional study, Italy, 23 February to 24 May 2020

Sforzi I.;Trapani S.;Parrino R.;Lubrano R.;Mariani I.
2021

Abstract

Background: Very few studies describe factors associated with COVID-19 diagnosis in children. Aim: We here describe characteristics and risk factors for COVID-19 diagnosis in children tested in 20 paediatric centres across Italy. Methods: We included cases aged 0-18 years tested between 23 February and 24 May 2020. Our primary analysis focused on children tested because of symptoms/signs suggestive of COVID-19. Results: Among 2,494 children tested, 2,148 (86.1%) had symptoms suggestive of COVID-19. Clinical presentation of confirmed COVID-19 cases included besides fever (82.4%) and respiratory signs or symptoms (60.4%) also gastrointestinal (18.2%), neurological (18.9%), cutaneous (3.8%) and other unspecific influenza-like presentations (17.8%). In multivariate analysis, factors significantly associated with SARSCoV-2 positivity were: exposure history (adjusted odds ratio (AOR): 39.83; 95% confidence interval (CI): 17.52-90.55; p<0.0001), cardiac disease (AOR: 3.10; 95% CI: 1.19-5.02; p<0.0001), fever (AOR: 3.05%; 95% CI: 1.67-5.58; p=0.0003) and anosmia/ ageusia (AOR: 4.08; 95% CI: 1.69-9.84; p=0.002). Among 190 (7.6%) children positive for SARS-CoV-2, only four (2.1%) required respiratory support and two (1.1%) were admitted to intensive care; all recovered. Conclusion: Recommendations for SARS-CoV-2 testing in children should consider the evidence of broader clinical features. Exposure history, fever and anosmia/ ageusia are strong risk factors in children for positive SARS-CoV-2 testing, while other symptoms did not help discriminate positive from negative individuals. This study confirms that COVID-19 was a mild disease in the general paediatric population in Italy. Further studies are needed to understand risk, clinical spectrum and outcomes of COVID-19 in children with preexisting conditions.
2021
26
1
12
Goal 3: Good health and well-being
Lazzerini M.; Sforzi I.; Trapani S.; Biban P.; Silvagni D.; Villa G.; Tibaldi J.; Bertacca L.; Felici E.; Perricone G.; Parrino R.; Gioe C.; Lega S.; ...espandi
File in questo prodotto:
File Dimensione Formato  
eurosurv-26-14-4.pdf

accesso aperto

Tipologia: Pdf editoriale (Version of record)
Licenza: Open Access
Dimensione 293.76 kB
Formato Adobe PDF
293.76 kB Adobe PDF

I documenti in FLORE sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificatore per citare o creare un link a questa risorsa: https://hdl.handle.net/2158/1400248
Citazioni
  • ???jsp.display-item.citation.pmc??? 25
  • Scopus 26
  • ???jsp.display-item.citation.isi??? 24
social impact